This inventor holds 5 USPTO granted patents and 6 published patent applications and 3 EPO patents. Top assignees: British Biotech Pharmaceuticals Limited, Chronos Therapeutics Limited, Oxford Biodynamics Plc. Active years: 1991-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Oxford, GB (1991 - 2017)
- Yarnton, GB (2020)
Company Filing History:
1 out of 85 
1 out of 4 
1 out of 11 Years Active: 1991-2020
Title: Innovations and Contributions of Elizabeth Jane Mellor
Introduction
Elizabeth Jane Mellor is a distinguished inventor based in Oxford, GB. She has made significant contributions to the field of genetics and epigenetics, holding a total of five patents. Her work focuses on innovative methods that enhance our understanding of chromosomal interactions and cellular aging.
Latest Patents
Among her latest patents is a method for detecting long-range chromosomal interactions. This invention relates to monitoring epigenetic changes by observing alterations in conditional long-range chromosomal interactions at specific loci associated with physiological conditions. Another notable patent is a method for assessing cell aging. This method involves capturing images of a population of organisms at different time points and calculating changes in mobility over time.
Career Highlights
Elizabeth has worked with Oxford Gene Systems Limited, where she applied her expertise in genetics to advance research and development. Her innovative approaches have contributed to the understanding of complex biological processes.
Collaborations
Throughout her career, Elizabeth has collaborated with notable professionals, including Alexandre Akoulitchev and Alan J Kingsman. These partnerships have further enriched her research and expanded the impact of her inventions.
Conclusion
Elizabeth Jane Mellor's contributions to the field of genetics through her patents and collaborations highlight her role as a leading inventor. Her innovative methods continue to influence research in epigenetics and cellular biology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile